-
EMA clarifies use of chloroquine and hydroxychloroquine for COVID-19
| 02 April 2020 |
Chloroquine and hydroxychloroquine must only be used for COVID-19 in clinical trials or national emergency use programmes in COVID-19 patients whose condition is critical, says the European Medicines Agency, EMA.
-
Clarification on companies’ notification of supply problems to the Danish Medicines Agency
| 01 April 2020 |
The Danish Medicines Agency would like to clarify when and how companies must notify the Danish Medicines Agency of any supply problems they might experience.
-
No evidence confirms reports that blood pressure medicines could worsen COVID-19
| 30 March 2020 |
After several specialist media and patient organisations in Denmark have disproved reports that ACE inhibitors and angiotensin receptor blockers could worsen the condition of COVID-19 patients, the European Medicines Agency now sends the same message.
-
Danish Medicines Agency initiates COVID-19 data analyses
| 27 March 2020 |
What is the drug consumption and medical history of Danish COVID-19 patients? And does the use of certain painkillers, including ibuprofen, affect the disease course of COVID-19?
-
Inquiries to the Danish Medicines Agency about medicines
| 27 March 2020 |
It is important to us that companies and industry associations feel they receive a prompt reply when they contact the Danish Medicines Agency.
-
More than 1,000 have responded to the Denmark helps Denmark campaign
| 27 March 2020 |
This weekend the Danish Medicines Agency launched the Denmark helps Denmark campaign wherein companies and manufacturers can make contributions to increase the supply of protective equipment like facemasks, gloves and shields for frontline staff. Thursday the number of responses exceeded 1,000.
-
COVID-19: Danish Medicines Agency puts inspection and control tasks on hold
| 26 March 2020 |
Due to the COVID-19 pandemic, the Danish Medicines Agency is putting all on-site inspections and laboratory controls on hold until further notice. The Danish Medicines Agency will, however, continue with office-based assessments and controls, and, if needed, also on-site inspections.
-
COVID-19: Watch out for illegal online sale
| 26 March 2020 |
Unauthorised retailers are illegally selling medicines and self-test kits online by exploiting fears and concerns amid the COVID-19 pandemic. “Extremely unsympathetic and dangerous to people’s lives and well-being,” says the Danish Medicines Agency’s Director General.
-
Paracetamol for children now only available from pharmacies
| 25 March 2020 |
Due to problems of supplying paracetamol for children, the Danish Medicines Agency is now taking action to ensure that there is enough for the children who need it the most. Director General of the Danish Medicines Agency: ”Buy only what you need”.
-
Danish Medicines Agency given more powers to counteract supply problems
| 24 March 2020 |
New rules have come into force, which means that companies, regions and municipalities may be ordered to report their supplies of medicines and medical devices to the Danish Medicines Agency, and that medicines and devices can be reallocated to areas in the healthcare service that need them the most.
-
COVID-19 and production of protective equipment: Collaboration between Danish Medicines Agency and Danish companies
| 24 March 2020 |
The Medicoindustrien, the Confederation of Danish Industry and the Danish Medicines Agency have formed a new collaboration to switch the production to gloves, lab coats, mouth shields, isolation gowns, masks and hand sanitizer.
-
New campaign to prevent shortage of protective equipment: Denmark helps Denmark
| 23 March 2020 |
The healthcare services are running short of protective equipment such as face masks and visors in many areas of Denmark. The Danish Medicines Agency now launches the “Denmark helps Denmark” campaign, urging authorities, companies and others to report it if they have excess equipment or ideas on how to procure more.
-
Risk of supply failure: Use protective equipment rationally
| 22 March 2020 |
There is a risk that the healthcare sector will run out of protective equipment, such as hand sanitizer, facemasks and visors/shields, which are crucial in the fight against coronavirus. We urge everyone to use at little as possible without compromising on safety.
-
Global action against illicit medicines and medical devices
| 20 March 2020 |
The global action Operation Pangea targeting the illicit sale of medicines and medical devices has now finished, and the results have been established. 635 parcels containing illegally imported medicines were seized in Denmark.
-
Restriction on sale of medicines in pharmacies (clarification)
| 19 March 2020 |
The Minister of Health has activated parts of the drug preparedness. This means that you cannot buy more prescription medicines at the pharmacy than what you normally use, and that the amount of OTC medicines being dispensed has been limited. The decision has been taken to avoid hoarding.
-
Fast-track Approval of Clinical Trials investigating COVID-19
| 17 March 2020 |
Clinical trials investigating treatments for COVID-19 will be processed within 3 days. The processing time is extended if major objections is raised but we prioritise to have these solved immediately.
-
All efforts taken to minimise supply disruption of medicines and medical devices
| 10 March 2020 |
Authorities and companies in Denmark and abroad are collaborating intensively to minimise potential disruptions in the supply chain of medicines and medical devices caused by the COVID-19 outbreak.
-
New enhanced reporting requirement is to strengthen the surveillance of medical devices
| 05 March 2020 |
A new rule imposing an enhanced reporting requirement on medical devices has just entered into force. The rule is to ensure that the surveillance of medical devices is strengthened and becomes more focused for the benefit of patients.
-
New head of the Danish Medicines Agency’s Data Analytics Centre
| 05 March 2020 |
The Danish Medicines Agency has hired Jesper Kjær as head of the Agency’s Data Analytics Centre as of 1 April. The Data Analytics Centre will officially open later this year.
-
The authorities are getting ready for fast-track approval of vaccines for coronavirus
| 17 February 2020 |
Drug regulatory authorities around the world are supporting researchers and companies in the fast development of a vaccine for coronavirus (2019-nCoV) and are getting ready to facilitate an approval as fast as possible without compromising safety.
